Locally Advanced or Metastatic Non-small Cell Lung Cancer
Also known as: Locally Advanced or Metastatic Non Small Cell Lung Cancer / Locally Advanced/ Metastatic NSCLC / Metastatic or Locally Advanced NSCLC / Locally Advanced or Metastatic NSCLC / Locally Advanced Metastatic NSCLC
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB16826 | Repotrectinib | A tyrosine kinase inhibitor used to treat locally active or metastatic non-small cell lung cancer |